Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline - Publication - Authors - KSSG Research Database

Publication

Long-Term Interruption of Enzyme Replacement Therapy with rhGAA in Pompe Disease Leads to Irreversible Clinical Decline

Journal Paper/Review - Jan 1, 2015

Hundsberger Thomas, Rösler Kai M, Findling Oliver

Hundsberger, Thomas

chief of service
Neurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I

Rösler, Kai M

Findling, Oliver